27 results
8-K
EX-99.1
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
Value Proposition PROOF POINTS PROOF POINTS PROOF POINTS *HCPs = healthcare professionals Sources: Munir et al. 2012; Munir et al. 2013; Ahmad et al
8-K
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
corporation (the “Company”) will participate in the 42nd Annual J.P. Morgan Healthcare Conference (the “Conference”). The Company has updated
8-K
EX-99.2
n3ljc2uy
13 Nov 23
IO Biotech Announces 2023 Third Quarter Results
8:10am
8-K
EX-99.1
bt83zrua5wwgott55zw
13 Nov 23
IO Biotech Announces 2023 Third Quarter Results
8:10am
424B2
oxb80fwek1
12 Sep 23
Prospectus for primary offering
4:06pm
8-K
EX-99.1
lzd5z07 djdz1
11 Aug 23
IO Biotech Announces 2023 Second Quarter Results
8:31am
8-K
EX-99.1
c6lme
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
PRE 14A
b2objwxcbcc i1psrc
14 Apr 23
Preliminary proxy
4:39pm
DEF 14A
j3pn0z9f7d
14 Apr 22
Definitive proxy
4:02pm
10-K
zyxyb2u4 at5
31 Mar 22
Annual report
5:07pm
10-Q
zaygef nq40
17 Dec 21
Quarterly report
4:55pm
8-K
EX-99.1
btejqidz09 f7qmgg7
17 Dec 21
Results of Operations and Financial Condition
4:40pm
8-K
EX-10.1
kanipzu
6 Dec 21
Entry into a Material Definitive Agreement
9:00am